NCT05274087View on ClinicalTrials.gov

Study to Evaluate the Effect of Different Warm-Up Times of Risankizumab Autoinjector (AI) on the Injection Pain Experiences in Healthy Volunteers

PHASE1CompletedINTERVENTIONAL
Enrollment

30

Participants

Timeline

Start Date

September 15, 2020

Primary Completion Date

April 7, 2021

Study Completion Date

April 7, 2021

Conditions
Healthy Volunteers
Interventions
DRUG

Risankizumab

Subcutaneous autoinjector

Trial Locations (1)

60030

Acpru /Id# 223662, Grayslake

Sponsors

Lead Sponsor

AbbVie
All Listed Sponsors
lead

AbbVie

INDUSTRY